Year archive

Alphamab Oncology — 2022 filings

All 51 regulatory filings released by Alphamab Oncology (9966) in 2022, sourced directly from the official regulator.

51 Filings

2022 Period

2022 filings (51)

Filing	Released	Lang
Terms of Reference of the Remuneration Committee Regulatory Filings	2022-12-28	English
VOLUNTARY ANNOUNCEMENT - PRESENTATION OF RESEARCH UPDATES ON KN046 AND KN026 AT THE SABCS 2022 Regulatory Filings	2022-12-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022 Regulatory Filings	2022-12-06	English
Next Day Disclosure Return Regulatory Filings	2022-11-24	English
Next Day Disclosure Return Regulatory Filings	2022-11-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 Regulatory Filings	2022-11-04	English
VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY NMPA FOR A PHASE IA/IB CLINICAL TRIAL OF JSKN003 FOR THE TREATMENT OF ADVANCED SOLID TUMORS Regulatory Filings	2022-10-27	English
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME Regulatory Filings	2022-10-24	English
GRANT OF SHARE OPTIONS Regulatory Filings	2022-10-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022 Regulatory Filings	2022-10-05	English
2022 INTERIM REPORT Regulatory Filings	2022-09-27	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE I CLINICAL TRIAL OF JSKN003 (KN026-ADC) IN AUSTRALIA FOR THE TREATMENT OF ADVANCED SOLID TUMORS Regulatory Filings	2022-09-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022 Regulatory Filings	2022-09-06	English
VOLUNTARY ANNOUNCEMENT - UPDATES ON CLINICAL DATA OF KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2022 Regulatory Filings	2022-09-05	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022 Regulatory Filings	2022-08-31	English
DATE OF BOARD MEETING Regulatory Filings	2022-08-18	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE II CLINICAL TRIAL OF KN046 COMBINED WITH AXITINIB FOR THE FIRST-LINE TREATMENT OF ADVANCED NSCLC Regulatory Filings	2022-08-08	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022 Regulatory Filings	2022-08-03	English
VOLUNTARY ANNOUNCEMENT - ABSTRACTS AND E-POSTERS OF RESEARCH UPDATES ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2022 Regulatory Filings	2022-07-29	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022 Regulatory Filings	2022-07-07	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Regulatory Filings	2022-06-16	English
RESIGNATION OF A NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE Regulatory Filings	2022-06-16	English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 10, 2022 Regulatory Filings	2022-06-10	English
Next Day Disclosure Return Regulatory Filings	2022-06-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022 Regulatory Filings	2022-06-06	English
2021 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2022-05-31	English
VOLUNTARY ANNOUNCEMENT - PRESENTATION OF RESEARCH UPDATES ON KN046 AND KN026 AT 2022 ASCO ANNUAL MEETING Regulatory Filings	2022-05-30	English
CLARIFICATION ANNOUNCEMENT Regulatory Filings	2022-05-30	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE II CLINICAL TRIAL OF KN026 COMBINED WITH PALBOCICLIB AND FULVESTRANT FOR THE TREATMENT OF LOCALLY ADVANCED UNRESECTABLE OR METASTATIC HER2-POSIT Regulatory Filings	2022-05-26	English
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME Regulatory Filings	2022-05-20	English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 10, 2022 Regulatory Filings	2022-05-10	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2022-05-10	English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITORS; AND Regulatory Filings	2022-05-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022 Regulatory Filings	2022-05-06	English
2021 Annual Report Regulatory Filings	2022-04-27	English
GRANT OF SHARE OPTIONS Regulatory Filings	2022-04-25	English
VOLUNTARY ANNOUNCEMENT - UPDATES ON CLINICAL DATA OF KN046 IN COMBINATION WITH KN026 FOR THE TREATMENT OF HER2-POSITIVE SOLID CANCER FOR PRESENTATION AT 2022 AACR ANNUAL MEETING Regulatory Filings	2022-04-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022 Regulatory Filings	2022-04-07	English
VOLUNTARY ANNOUNCEMENT - THE FIRST INTERIM ANALYSIS OF A PHASE III CLINICAL TRIAL OF KN046 SUCCESSFULLY REACHED PRESPECIFIED PFS ENDPOINT Regulatory Filings	2022-03-31	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021 Regulatory Filings	2022-03-29	English
DATE OF BOARD MEETING Regulatory Filings	2022-03-11	English
VOLUNTARY ANNOUNCEMENT - PRELIMINARY RESULTS OF PHASE II CLINICAL TRIAL OF KN046 IN COMBINATION WITH KN026 FOR THE TREATMENT OF LOCALLY ADVANCED UNRESECTABLE OR METASTATIC HER2-POSITIVE SOLID CANCER A Regulatory Filings	2022-03-09	English
Next Day Disclosure Return Regulatory Filings	2022-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022 Regulatory Filings	2022-03-03	English
VOLUNTARY ANNOUNCEMENT - IND APPROVALS BY NMPA FOR A PHASE IA/IB CLINICAL TRIAL OF KN052 IN THE TREATMENT OF ADVANCED SOLID TUMORS AND A PHASE II CLINICAL TRIAL OF KN046 IN COMBINATION WITH AXITI Regulatory Filings	2022-02-10	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE III CLINICAL TRIAL OF KN046 FOR THE TREATMENT OF ADVANCED PDAC Regulatory Filings	2022-02-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022 Regulatory Filings	2022-02-08	English
GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME Regulatory Filings	2022-01-27	English
CONTINUING CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE MASTER TECHNICAL SERVICE AGREEMENT Regulatory Filings	2022-01-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021 Regulatory Filings	2022-01-06	English
CONNECTED TRANSACTION ANNOUNCEMENT - RENEWAL OF THE LEASE AGREEMENT Regulatory Filings	2022-01-03	English

Filings by year

2026 26 filings
2025 66 filings
2024 57 filings
2023 49 filings
2022 51 filings
2021 48 filings
2020 50 filings
2019 20 filings